The information
in this Prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Prospectus is not an offer to sell these securities and it
is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION DATED DECEMBER 1, 2021
FORM OF PROSPECTUS SUPPLEMENT
Blackstone Senior Floating Rate Term Fund
Up to [ ] Common Shares
The Fund. Blackstone Senior Floating Rate Term Fund (the Fund) is a diversified, closed-end management investment company.
Investment Objectives. The Fund is a
diversified, closed-end management investment company. The Funds primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with
its primary goal of high current income. There can be no assurance that the Fund will achieve its investment objectives. The Fund seeks to achieve these investment objectives by investing primarily in senior, secured floating rate loans
(Senior Loans). Under normal market conditions Blackstone Liquid Credit Strategies LLC (the Adviser), the Funds investment adviser, expects the Fund to maintain an average duration of less than one year (including the
effect of anticipated leverage).
Investment Strategies. Under normal market conditions, the Fund will invest at
least 80% of its Managed Assets (as defined below) in Senior Loans. Senior Loans are made to U.S. and, to a limited extent, non-U.S. corporations, partnerships and other business entities
(Borrowers) which operate in various industries and geographical regions. Senior Loans pay interest at rates which are determined periodically on the basis of a floating base lending rate, primarily the London-Interbank Offered Rate
(LIBOR), or a replacement rate in the event that LIBOR is discontinued, plus a premium. Senior Loans typically are of below investment grade quality. Below investment grade quality instruments (including Senior Loans) are those that, at
the time of investment, are rated Ba1 or lower by Moodys Investors Service, Inc. (Moodys) and BB+ or lower by Standard & Poors Corporation Ratings Group (S&P) or Fitch Ratings, Inc.
(Fitch), or if unrated are determined by the Adviser to be of comparable quality. Below investment grade instruments, commonly referred to as junk or high yield securities, are high risk and have speculative
characteristics.
The Fund may invest up to 20% of its Managed Assets in (i) loan interests that are not secured by any collateral of
the Borrower, (ii) loan interests that have a lower than first lien priority on collateral of the Borrower, (iii) other income producing securities (including, without limitation, U.S. government debt securities and investment and non-investment grade, subordinated and unsubordinated corporate debt securities), (iv) warrants and equity securities issued by a Borrower or its affiliates as part of a package of investments in the Borrower or its
affiliates and (v) structured products (including, without limitation, collateralized loan obligations, credit linked notes and derivatives, including credit derivatives).
This Prospectus Supplement, together with the accompanying Prospectus dated [ ], 2022 sets forth the information that
you should know before investing.
The Funds common shares of beneficial interest (Common Shares) are listed on the New
York Stock Exchange (the Exchange) and trade under the ticker symbol BSL. The net asset value (NAV) of the Common Shares at the close of business on [ ], 2022 was
$[ ] per share, and the last sale price per share of the Common Shares on the Exchange on that date was $[ ]. Shares of
closed-end funds often trade at a discount from NAV.
You should read this Prospectus Supplement
and the accompanying Prospectus (which includes a Statement of Additional Information, dated [ ], 2022, containing additional information about the Fund, which has been filed with the Securities and Exchange Commission (the
SEC) and, as amended from time to time, is incorporated by reference in its entirety into this Prospectus. You may request a free copy of the Statement of Additional Information, annual and semi-annual reports to shareholders (when
available), and additional information about the Fund and make shareholder inquiries by calling toll-free (800) 522-6645, by writing to the Fund or visiting the Funds website
(http://www.blackstone.com/bsl/). You can access the same documents, including any materials incorporated by reference, free from the SECs website (http://www.sec.gov). You may also e-mail requests for
these documents to publicinfo@sec.gov.
Investing in the Funds securities involves certain risks. See beginning on page 58 of the
accompanying Prospectus.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this
Prospectus Supplement or the accompanying Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
|
|
|
|
|
|
|
|
|
|
|
Per Share
|
|
|
Total
|
|
Public offering price
|
|
$
|
|
|
|
$
|
|
|
Sales load
|
|
$
|
|
|
|
$
|
|
|
Proceeds, after expenses, to the Fund
|
|
$
|
|
|
|
$
|
|
|
[We have granted the underwriters an option to purchase up to an additional Common Shares at the public
offering price, less the underwriting discount, to cover over-allotments, if any, within days from the date of this Prospectus Supplement. If the underwriters exercise the option in full, the total underwriting discount will be $ , and the proceeds,
before expenses, to us will be $[ ].]
[Underwriter(s)]
This Prospectus Supplement is dated [ ], 2022
The Funds securities do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured
depository institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.
Capitalized terms used herein that are not otherwise defined shall have the meanings assigned to them in the accompanying Prospectus.